查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451617

2024-2032 年按技術、應用、產品、樣本、最終用戶和地區分類的循環腫瘤細胞市場報告

Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球循環腫瘤細胞（CTC）市場規模達到118億美元。展望未來， IMARC Group預計到2032年市場規模將達到261億美元，2024-2032年複合年成長率（CAGR）為8.9%。

循環腫瘤細胞（CTC）是從原發腫瘤中分裂出來並以單一單位或簇的形式出現在循環系統中的癌細胞。它們具有不同的生物學表現型，例如上皮型、間質型和上皮-間質混合型。患者血液中的 CTC 水平可以早期發現癌症並作為預後指標。由於 CTC 的數量很少，因此採用了多種技術來分離、富集和檢測 CTC，例如免疫捕獲、基於大小的分離、基於密度的分離和顯微鏡檢查。它在液體活體組織切片、癌症研究、藥物開發和臨床生物標記方面也有廣泛的應用。

循環腫瘤細胞 (CTC) 市場趨勢：

由於遺傳性疾病、飲酒量增加和生活方式的快速改變，癌症盛行率不斷上升，是推動市場成長的關鍵因素。 CTC 有助於肺癌、乳腺癌、消化道癌和前列腺癌的早期識別和即時監測。與此一致的是，CTC 在患者轉移篩檢和新抗癌藥物臨床前研究的使用不斷增加，有利於市場成長。此外，對微創 (MI) 診斷程序的需求不斷成長，以及基於 CTC 的液體活體組織切片的廣泛採用，以實現快速康復和限制創傷，這為市場成長提供了相當大的推動力。除此之外，引入奈米技術來提高 CTC 分離和檢測的靈敏度和效率也為市場成長提供了動力。此外，醫學研究中擴大利用細胞培養模型來開發用於藥物篩選、疾病建模、基因組編輯和腫瘤免疫的細胞培養模型，這為市場創造了積極的前景。此外，醫療保健專業人員和患者對早期癌症診斷重要性的認知不斷提高，對市場成長產生了積極影響。其他因素，包括生物醫學影像和生物工程技術的快速進步、廣泛的研發（R＆D）活動以及對預防醫學和伴隨診斷不斷成長的需求，預計將推動市場成長。

本報告回答的關鍵問題

  • 2023年全球循環腫瘤細胞（CTC）市場規模有多大？
  • 2024-2032年全球循環腫瘤細胞（CTC）市場的預期成長率是多少？
  • 推動全球循環腫瘤細胞（CTC）市場的關鍵因素是什麼？
  • COVID-19 對全球循環腫瘤細胞 (CTC) 市場有何影響？
  • 基於此技術的全球循環腫瘤細胞（CTC）市場的詳細情形如何？
  • 基於該應用的全球循環腫瘤細胞 (CTC) 市場的詳細情形如何？
  • 基於該產品的全球循環腫瘤細胞 (CTC) 市場的詳細情形如何？
  • 根據樣本，全球循環腫瘤細胞 (CTC) 市場的詳細情形如何？
  • 全球循環腫瘤細胞（CTC）市場的關鍵區域有哪些？
  • 誰是全球循環腫瘤細胞（CTC）市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球循環腫瘤細胞 (CTC) 市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依技術

  • CTC檢測及富集方法
    • 市場走向
    • 市場預測
  • CTC直接檢測方法
    • 市場走向
    • 市場預測
  • CTC分析
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 臨床/液體活體組織切片
    • 市場走向
    • 關鍵環節
      • 風險評估
      • 篩檢和監測
    • 市場預測
  • 研究
    • 市場走向
    • 關鍵環節
      • 癌症幹細胞和腫瘤發生研究
      • 藥物/療法開發
    • 市場預測

第 8 章：市場區隔：依產品

  • 試劑盒和試劑
    • 市場走向
    • 市場預測
  • 採血管
    • 市場走向
    • 市場預測
  • 設備或系統
    • 市場走向
    • 市場預測

第 9 章：市場區隔：依樣本

  • 血
    • 市場走向
    • 市場預測
  • 骨髓
    • 市場走向
    • 市場預測
  • 其他體液
    • 市場走向
    • 市場預測

第 10 章：市場區隔：依最終用戶

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 研究和學術機構
    • 市場走向
    • 市場預測
  • 診斷中心
    • 市場走向
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • BioFluidica Inc
    • Creatv MicroTech Inc.
    • CytoLumina Technologies Corp.
    • Fluxion Biosciences Inc.
    • Greiner Bio-One International GmbH
    • Ikonisys Inc
    • Menarini Silicon Biosystems
    • Miltenyi Biotec
    • Qiagen NV
    • Rarecells Diagnostics
    • Stemcell Technologies
Product Code: SR112024A6316

The global circulating tumor cells (CTC) market size reached US$ 11.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.1 Billion by 2032, exhibiting a growth rate (CAGR) of 8.9% during 2024-2032.

Circulating tumor cells (CTC) are cancer cells that split away from the primary tumor and appear in the circulatory system as singular units or clusters. They have different biological phenotypes, such as epithelial, mesenchymal, and mixed epithelial-mesenchymal. CTC levels in a patient's blood can allow early detection of cancer and act as a prognostic indicator. As they are in minimal quantity, several technologies are used for the isolation, enrichment, and detection of CTC, such as immunocapture, size-based separation, density-based separation, and microscopy. It also has wide-ranging applications in liquid biopsy, cancer research, drug development, and clinical biomarkers.

Circulating Tumor Cells (CTC) Market Trends:

The increasing prevalence of cancer due to genetic disorders, rising alcohol consumption, and rapid lifestyle changes are key factors driving the market growth. CTC assists in the early identification and real-time monitoring of lung, breast, digestive tract, and prostate cancer. In line with this, the increasing utilization of CTC in patient screening for metastasis and preclinical studies of new cancer drugs is favoring the market growth. Furthermore, the growing demand for minimally invasive (MI) diagnostic procedures and widespread adoption of CTC-based liquid biopsy to enable rapid recovery and limit trauma are providing a considerable boost to the market growth. Apart from this, the introduction of nanotechnology to improve the sensitivity and efficiency of CTC isolation and detection is providing an impetus to market growth. Moreover, increasing utilization in medical research to develop cell culture models for drug screening, disease modeling, genome editing, and tumor immunity is creating a positive outlook for the market. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early cancer diagnosis is positively influencing the market growth. Other factors, including rapid advancements in biomedical imaging and bioengineering technology, extensive research and development (R&D) activities, and the rising demand for preventive medicine and companion diagnostics, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global circulating tumor cells (CTC) market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology, application, product, specimen and end user.

Breakup by Technology:

CTC Detection and Enrichment Method

CTC Direct Detection Methods

CTC Analysis

Breakup by Application:

Clinical/Liquid Biopsy

Risk Assessment

Screening and Monitoring

Research

Cancer Stem Cell and Tumorigenesis Research

Drug/Therapy Development

Breakup by Product:

Kits and Reagents

Blood Collection Tubes

Devices and Systems

Breakup by Specimen:

Blood

Bone Marrow

Other Body Fluids

Breakup by End User:

Hospital and Clinics

Research and Academic Institutes

Diagnostic Centres

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnostics and Stemcell Technologies.

Key Questions Answered in This Report

  • 1. What was the size of the global Circulating Tumor Cells (CTC) market in 2023?
  • 2. What is the expected growth rate of the global Circulating Tumor Cells (CTC) market during 2024-2032?
  • 3. What are the key factors driving the global Circulating Tumor Cells (CTC) market?
  • 4. What has been the impact of COVID-19 on the global Circulating Tumor Cells (CTC) market?
  • 5. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the technology?
  • 6. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the application?
  • 7. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the product?
  • 8. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the specimen?
  • 9. What are the key regions in the global Circulating Tumor Cells (CTC) market?
  • 10. Who are the key players/companies in the global Circulating Tumor Cells (CTC) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Circulating Tumor Cells (CTC) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 CTC Detection and Enrichment Method
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 CTC Direct Detection Methods
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CTC Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Clinical/Liquid Biopsy
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Risk Assessment
      • 7.1.2.2 Screening and Monitoring
    • 7.1.3 Market Forecast
  • 7.2 Research
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Cancer Stem Cell and Tumorigenesis Research
      • 7.2.2.2 Drug/Therapy Development
    • 7.2.3 Market Forecast

8 Market Breakup by Product

  • 8.1 Kits and Reagents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Blood Collection Tubes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Devices or Systems
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Specimen

  • 9.1 Blood
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Bone Marrow
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Other Body Fluids
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospital and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research and Academic Institutes
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Diagnostic Centres
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 BioFluidica Inc
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Creatv MicroTech Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 CytoLumina Technologies Corp.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Fluxion Biosciences Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Greiner Bio-One International GmbH
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Ikonisys Inc
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Menarini Silicon Biosystems
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Miltenyi Biotec
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Qiagen N.V
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Rarecells Diagnostics
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Stemcell Technologies
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Circulating Tumor Cells Market: Major Drivers and Challenges
  • Figure 2: Global: Circulating Tumor Cells Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Circulating Tumor Cells Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Circulating Tumor Cells Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Circulating Tumor Cells Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Circulating Tumor Cells Market: Breakup by Product (in %), 2023
  • Figure 7: Global: Circulating Tumor Cells Market: Breakup by Specimen (in %), 2023
  • Figure 8: Global: Circulating Tumor Cells Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Circulating Tumor Cells Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Circulating Tumor Cells (CTC Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Circulating Tumor Cells (CTC Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Circulating Tumor Cells (Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Circulating Tumor Cells (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Circulating Tumor Cells (Kits and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Circulating Tumor Cells (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Circulating Tumor Cells (Blood Collection Tubes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Circulating Tumor Cells (Blood Collection Tubes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Circulating Tumor Cells (Devices or Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Circulating Tumor Cells (Devices or Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Circulating Tumor Cells (Blood) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Circulating Tumor Cells (Blood) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Circulating Tumor Cells (Bone Marrow) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Circulating Tumor Cells (Bone Marrow) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Circulating Tumor Cells (Other Body Fluids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Circulating Tumor Cells (Other Body Fluids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Circulating Tumor Cells (Hospital and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Circulating Tumor Cells (Hospital and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Circulating Tumor Cells (Research and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Circulating Tumor Cells (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Circulating Tumor Cells (Diagnostic Centres) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Circulating Tumor Cells (Diagnostic Centres) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Circulating Tumor Cells Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Circulating Tumor Cells Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Circulating Tumor Cells Industry: SWOT Analysis
  • Figure 88: Global: Circulating Tumor Cells Industry: Value Chain Analysis
  • Figure 89: Global: Circulating Tumor Cells Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Circulating Tumor Cells Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Circulating Tumor Cells Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 3: Global: Circulating Tumor Cells Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Circulating Tumor Cells Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 5: Global: Circulating Tumor Cells Market Forecast: Breakup by Specimen (in Million US$), 2024-2032
  • Table 6: Global: Circulating Tumor Cells Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Circulating Tumor Cells Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Circulating Tumor Cells Market: Competitive Structure
  • Table 9: Global: Circulating Tumor Cells Market: Key Players